Literature DB >> 22497807

Human cytomegalovirus US3 modulates destruction of MHC class I molecules.

Vanessa M Noriega1, Julia Hesse, Thomas J Gardner, Katrin Besold, Bodo Plachter, Domenico Tortorella.   

Abstract

Human cytomegalovirus (HCMV), a member of the Herpesviridae family, is proficient at establishing lifelong persistence within the host in part due to immune modulating genes that limit immune recognition. HCMV encodes at least five glycoproteins within its unique short (US) genomic region that interfere with MHC class I antigen presentation, thus hindering viral clearance by cytotoxic T lymphocytes (CTL). Specifically, US3 retains class I within the endoplasmic reticulum (ER), while US2 and US11 induce class I heavy chain destruction. A cooperative effect on class I down-regulation during stable expression of HCMV US2 and US3 has been established. To address the impact of US3 on US11-mediated MHC class I down-regulation, the fate of class I molecules was examined in US3/US11-expressing cells and virus infection studies. Co-expression of US3 and US11 resulted in a decrease of surface expression of class I molecules. However, the class I molecules in US3/US11 cells were mostly retained in the ER with an attenuated rate of proteasome destruction. Analysis of class I levels from virus-infected cells using HCMV variants either expressing US3 or US11 revealed efficient surface class I down-regulation upon expression of both viral proteins. Cells infected with both US3 and US11 expressing viruses demonstrate enhanced retention of MHC class I complexes within the ER. Collectively, the data suggests a paradigm where HCMV-induced surface class I down-regulation occurs by diverse mechanisms dependent on the expression of specific US genes. These results validate the commitment of HCMV to limiting the surface expression of class I levels during infection.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22497807      PMCID: PMC3367378          DOI: 10.1016/j.molimm.2012.03.024

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  29 in total

Review 1.  Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology.

Authors:  D Tortorella; B Gewurz; D Schust; M Furman; H Ploegh
Journal:  Immunol Invest       Date:  2000-05       Impact factor: 3.657

2.  Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene.

Authors:  Dong Yu; Gregory A Smith; Lynn W Enquist; Thomas Shenk
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA.

Authors:  E C Lee; D Yu; J Martinez de Velasco; L Tessarollo; D A Swing; D L Court; N A Jenkins; N G Copeland
Journal:  Genomics       Date:  2001-04-01       Impact factor: 5.736

4.  Dislocation of a type I membrane protein requires interactions between membrane-spanning segments within the lipid bilayer.

Authors:  Brendan N Lilley; Domenico Tortorella; Hidde L Ploegh
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

5.  The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules.

Authors:  Margo H Furman; Neelendu Dey; Domenico Tortorella; Hidde L Ploegh
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules.

Authors:  H Ziegler; W Muranyi; H G Burgert; E Kremmer; U H Koszinowski
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

Review 7.  Immune evasion by human cytomegalovirus: lessons in immunology and cell biology.

Authors:  W A Loenen; C A Bruggeman; E J Wiertz
Journal:  Semin Immunol       Date:  2001-02       Impact factor: 11.130

8.  Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion.

Authors:  Boyoun Park; Youngkyun Kim; Jinwook Shin; Sunray Lee; Kwangmin Cho; Klaus Früh; Sungwook Lee; Kwangseog Ahn
Journal:  Immunity       Date:  2004-01       Impact factor: 31.745

Review 9.  Human cytomegalovirus immunity and immune evasion.

Authors:  Sarah E Jackson; Gavin M Mason; Mark R Wills
Journal:  Virus Res       Date:  2010-11-05       Impact factor: 3.303

10.  Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus.

Authors:  Markus Wagner; Anja Gutermann; Jürgen Podlech; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  20 in total

Review 1.  Origins of natural killer cell memory: special creation or adaptive evolution.

Authors:  Kayla A Holder; Emilie M Comeau; Michael D Grant
Journal:  Immunology       Date:  2018-02-15       Impact factor: 7.397

2.  Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.

Authors:  Vanessa M Noriega; Kester K Haye; Thomas A Kraus; Shanna R Kowalsky; Yongchao Ge; Thomas M Moran; Domenico Tortorella
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation.

Authors:  Michael L van de Weijer; Anouk B C Schuren; Dick J H van den Boomen; Arend Mulder; Frans H J Claas; Paul J Lehner; Robert Jan Lebbink; Emmanuel J H J Wiertz
Journal:  J Cell Sci       Date:  2017-07-25       Impact factor: 5.285

4.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

5.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

6.  Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication.

Authors:  Kevin Brulois; Zsolt Toth; Lai-Yee Wong; Pinghui Feng; Shou-Jiang Gao; Armin Ensser; Jae U Jung
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells.

Authors:  Ildar Gabaev; Endrit Elbasani; Stefanie Ameres; Lars Steinbrück; Richard Stanton; Marius Döring; Tihana Lenac Rovis; Ulrich Kalinke; Stipan Jonjic; Andreas Moosmann; Martin Messerle
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 8.  The use of microRNA by human viruses: lessons from NK cells and HCMV infection.

Authors:  Tal Goldberger; Ofer Mandelboim
Journal:  Semin Immunopathol       Date:  2014-09-19       Impact factor: 11.759

9.  The genetic polymorphisms of HLA are strongly correlated with the disease severity after Hantaan virus infection in the Chinese Han population.

Authors:  Ying Ma; Bin Yuan; Jing Yi; Ran Zhuang; Jiuping Wang; Yun Zhang; Zhuwei Xu; Yusi Zhang; Bei Liu; Chao Wei; Chunmei Zhang; Angang Yang; Boquan Jin
Journal:  Clin Dev Immunol       Date:  2012-10-08

10.  Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.

Authors:  Stefanie Ameres; Josef Mautner; Fabian Schlott; Michael Neuenhahn; Dirk H Busch; Bodo Plachter; Andreas Moosmann
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.